{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:01:03Z","timestamp":1777309263260,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRP391513"],"award-info":[{"award-number":["CMRP391513"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3A0512"],"award-info":[{"award-number":["CMRPG3A0512"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC 101-2120-M-007-015-CC1"],"award-info":[{"award-number":["NSC 101-2120-M-007-015-CC1"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.biomaterials.2013.07.021","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T10:17:40Z","timestamp":1374661060000},"page":"7994-8001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT"],"prefix":"10.1016","volume":"34","author":[{"given":"Er-Yuan","family":"Chuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giang Thi Ha","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Yi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung-Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fwu-Long","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Chen","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyuhn-Huarng","family":"Juang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsing-Wen","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2013.07.021_bib1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Defronzo","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0889-8529(05)70222-X","article-title":"Insulin therapy in type 2 diabetes","volume":"30","author":"Mudaliar","year":"2001","journal-title":"Endocrin Metab Clin"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2337\/diaspect.17.3.183","article-title":"Glucose metabolism and regulation: beyond insulin and glucagon","volume":"17","author":"Aronoff","year":"2004","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib4","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2337\/diacare.28.11.2673","article-title":"Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes, and needs (DAWN) study","volume":"28","author":"Peyrot","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib5","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib6","first-page":"665","article-title":"Optimizing combination treatment in the management of type 2 diabetes","volume":"3","author":"Derosa","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib7","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/0003-4819-154-2-201101180-00300","article-title":"Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial","volume":"154","author":"Buse","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0168-8227(99)00099-6","article-title":"Injection related anxiety in insulin-treated diabetes","volume":"46","author":"Zambanini","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery","volume":"35","author":"Carino","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00063030-200519030-00003","article-title":"Oral delivery of peptide drugs: barriers and developments","volume":"19","author":"Hamman","year":"2005","journal-title":"Biodrugs"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib12","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1002\/adfm.201001014","article-title":"Self-assembled pH-sensitive nanoparticles: a platform for oral delivery of protein drugs","volume":"20","author":"Sonaje","year":"2010","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/ar200234q","article-title":"pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications","volume":"45","author":"Sung","year":"2012","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/mp200572t","article-title":"Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations","volume":"9","author":"Sonaje","year":"2012","journal-title":"Mol Pharmaceut"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib15","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.biomaterials.2008.12.066","article-title":"In\u00a0vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery","volume":"30","author":"Sonaje","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib16","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.biomaterials.2010.12.044","article-title":"The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in\u00a0vivo","volume":"32","author":"Nguyen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib17","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.2337\/diacare.20.12.1822","article-title":"Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes","volume":"20","author":"Avignon","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2013.05.006","article-title":"Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in\u00a0diabetic rats","author":"Chuang","year":"2013","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib19","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.biocel.2005.09.007","article-title":"Animal models of type 2 diabetes with reduced pancreatic beta-cell mass","volume":"38","author":"Masiello","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib20","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biomaterials.2011.12.038","article-title":"Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery","volume":"33","author":"Su","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/pharmaceutics3020141","article-title":"Live cell in\u00a0vitro and in\u00a0vivo imaging applications: accelerating drug discovery","volume":"3","author":"Isherwood","year":"2011","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib22","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1016\/j.biomaterials.2009.08.030","article-title":"The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin","volume":"30","author":"Chen","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib23","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1016\/j.biomaterials.2010.05.042","article-title":"Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib24","first-page":"1507","article-title":"Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET","volume":"41","author":"Hara","year":"2000","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib25","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2967\/jnumed.107.044362","article-title":"18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?","volume":"48","author":"Hellwig","year":"2007","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/1520915041705929","article-title":"The physiological rationale for oral insulin administration","volume":"6","author":"Arbit","year":"2004","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib27","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1210\/jc.2002-021545","article-title":"Synthetic exendin-4 (Exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes","volume":"88","author":"Kolterman","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/bc700292v","article-title":"Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery","volume":"19","author":"Chae","year":"2008","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1124\/jpet.110.175752","article-title":"Pharmacokinetic and pharmacodynamic modeling of exendin-4 in type 2 diabetic Goto-Kakizaki rats","volume":"336","author":"Gao","year":"2011","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib30","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2967\/jnumed.108.055442","article-title":"Small-animal SPECT and SPECT\/CT: important tools for preclinical investigation","volume":"49","author":"Franc","year":"2008","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrendo.2011.30","article-title":"Pharmacotherapy: GLP-1 analogues and insulin: sound the wedding bells?","volume":"7","author":"Nauck","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1148\/rg.242025724","article-title":"An introduction to PET-CT imaging","volume":"24","author":"Kapoor","year":"2004","journal-title":"Radiographics"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrm782","article-title":"Regulated transport of the glucose transporter glut4","volume":"3","author":"Bryant","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00259-008-0936-5","article-title":"Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET\/CT in primary cervical cancer","volume":"36","author":"Ho","year":"2009","journal-title":"Eur J Nucl Med Mol"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib35","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(75)92078-4","article-title":"Functional subdivision of islets of Langerhans and possible role of D cells","volume":"2","author":"Orci","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib36","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/diabetes.48.12.2270","article-title":"Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats","volume":"48","author":"Xu","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00125-006-0566-z","article-title":"Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus","volume":"50","author":"Knop","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.biomaterials.2013.07.021_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.regpep.2003.10.028","article-title":"Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes","volume":"117","author":"Nielsen","year":"2004","journal-title":"Regul Pept"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121300803X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121300803X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:50:56Z","timestamp":1758901856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296121300803X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":38,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S014296121300803X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.07.021","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}